CLINICAL_TRIALS
research
· 2025-04-30
Clinical Trial Update: Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia [EARLY_Phase 1]
Summary
Early-phase 1 clinical trial evaluating low-dose oral minoxidil as a treatment for permanent chemotherapy-induced alopecia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwestern University | Conditions: Permanent Chemotherapy-induced Alopecia | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING